# Estrogen and related hormone effects

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/estrogen-and-related-hormone-effects/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers explores the mechanisms of estrogen receptor signaling, with a focus on its role in breast cancer, interactions with glucocorticoids, and the effects of various drugs such as tamoxifen and aromatase inhibitors. It delves into the molecular pathways, gene regulation, and coactivator/coregulator dynamics involved in estrogen signaling. |
| Domain | Life Sciences |
| Field | Biochemistry, Genetics and Molecular Biology |
| OpenAlex ID | t10756 |
| Works | 283 |

## Topic papers all

Showing 15 of 283.

- [A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer](https://scholariq.org/papers/a-multigene-assay-to-predict-recurrence-of-tamoxifen-treated-node-negative/)
- [Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study](https://scholariq.org/papers/tamoxifen-for-prevention-of-breast-cancer-report-of-the-national-surgical/)
- [Cyclooxygenase in biology and disease](https://scholariq.org/papers/cyclooxygenase-in-biology-and-disease/)
- [Differential oestrogen receptor binding is associated with clinical outcome in breast cancer](https://scholariq.org/papers/differential-oestrogen-receptor-binding-is-associated-with-clinical-outcome-in/)
- [Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor](https://scholariq.org/papers/ligand-independent-repression-by-the-thyroid-hormone-receptor-mediated-by-a/)
- [The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women](https://scholariq.org/papers/the-effect-of-raloxifene-on-risk-of-breast-cancer-in-postmenopausal-women/)
- [A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-letrozole-in-postmenopausal-women-after-five-years-of/)
- [A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-exemestane-after-two-to-three-years-of-tamoxifen-therapy/)
- [Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.](https://scholariq.org/papers/selectivity-of-nonsteroidal-antiinflammatory-drugs-as-inhibitors-of-constitutive/)
- [Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease](https://scholariq.org/papers/effect-of-oestrogen-during-menopause-on-risk-and-age-at-onset-of-alzheimer-s/)
- [Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials](https://scholariq.org/papers/menopausal-hormone-therapy-and-health-outcomes-during-the-intervention-and/)
- [The Coxibs, Selective Inhibitors of Cyclooxygenase-2](https://scholariq.org/papers/the-coxibs-selective-inhibitors-of-cyclooxygenase-2/)
- [Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update](https://scholariq.org/papers/estrogen-and-progesterone-receptor-testing-in-breast-cancer-asco-cap-guideline/)
- [The Emergence of the Metabolic Syndrome with Menopause](https://scholariq.org/papers/the-emergence-of-the-metabolic-syndrome-with-menopause/)
- [Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2](https://scholariq.org/papers/systemic-biosynthesis-of-prostacyclin-by-cyclooxygenase-cox-2-the-human/)

## Topic primary papers

Showing 15 of 70.

- [Differential oestrogen receptor binding is associated with clinical outcome in breast cancer](https://scholariq.org/papers/differential-oestrogen-receptor-binding-is-associated-with-clinical-outcome-in/)
- [The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women](https://scholariq.org/papers/the-effect-of-raloxifene-on-risk-of-breast-cancer-in-postmenopausal-women/)
- [A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-letrozole-in-postmenopausal-women-after-five-years-of/)
- [A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-exemestane-after-two-to-three-years-of-tamoxifen-therapy/)
- [A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression](https://scholariq.org/papers/a-complex-containing-n-cor-msln3-and-histone-deacetylase-mediates/)
- [Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer](https://scholariq.org/papers/mechanisms-of-tamoxifen-resistance-increased-estrogen-receptor-her2-neu-cross/)
- [Aromatase Inhibitors in Breast Cancer](https://scholariq.org/papers/aromatase-inhibitors-in-breast-cancer/)
- [Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women](https://scholariq.org/papers/prevention-of-breast-cancer-with-tamoxifen-preliminary-findings-from-the-italian/)
- [Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial](https://scholariq.org/papers/continued-breast-cancer-risk-reduction-in-postmenopausal-women-treated-with/)
- [Progesterone receptor modulates ERα action in breast cancer](https://scholariq.org/papers/progesterone-receptor-modulates-er-action-in-breast-cancer/)
- [Progesterone Receptor Contains a Proline-Rich Motif that Directly Interacts with SH3 Domains and Activates c-Src Family Tyrosine Kinases](https://scholariq.org/papers/progesterone-receptor-contains-a-proline-rich-motif-that-directly-interacts-with/)
- [Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium](https://scholariq.org/papers/stromal-estrogen-receptors-mediate-mitogenic-effects-of-estradiol-on-uterine/)
- [Modulation of Antioxidant Enzyme Expression and Function by Estrogen](https://scholariq.org/papers/modulation-of-antioxidant-enzyme-expression-and-function-by-estrogen/)
- [Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway](https://scholariq.org/papers/estrogen-receptor-rapidly-activates-the-igf-1-receptor-pathway/)
- [Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids](https://scholariq.org/papers/reversal-of-bone-loss-in-mice-by-nongenotropic-signaling-of-sex-steroids/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.